Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.prro.2011.06.006 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
"Recognizing baroreflex failure syndrome in patients undergoing carotid body tumor resection: A call for awareness".
Eur J Surg Oncol
December 2024
Islamic International Medical College, Peshawar Road, Rawalpindi, 44000, Pakistan. Electronic address:
24-Month Outcomes of Endovascular Baroreflex Amplification With the MobiusHD Device in Heart Failure With Reduced Ejection Fraction.
JACC Heart Fail
January 2025
The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Reply to: "Recognizing Baroreflex failure syndrome in patients undergoing carotid body tumor resection: A call for awareness".
Eur J Surg Oncol
December 2024
Section of Vascular Surgery and Endovascular Therapy, Department of Surgery, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico; Programa de Maestría y Doctorado en Ciencias Médicas, Odontológicas y de La Salud, Universidad Nacional Autonoma de Mexico, Mexico City, Mexico. Electronic address:
Baroreflex activation therapy through electrical carotid sinus stimulation.
Auton Neurosci
December 2024
Department for Cardiology, Angiology, Pneumology and Intensive Care Medicine, University of Cologne, Germany; Department of Cardiology and Intensive Care Medicine, Ev. Krankenhaus Köln-Weyertal, Cologne, Germany.
An imbalance between cardiovascular parasympathetic and sympathetic activity towards sympathetic predominance has been implicated in the pathogenesis of treatment-resistant arterial hypertension and heart failure. Arterial baroreceptors control efferent cardiovascular autonomic activity and have, therefore, been recognized as potential treatment targets. Baroreflex activation therapy through electrical carotid sinus stimulation is a device-based approach to modulate cardiovascular autonomic activity.
View Article and Find Full Text PDFAcute right-sided transcutaneous vagus nerve stimulation improves cardio-vagal baroreflex gain in patients with chronic heart failure.
Clin Auton Res
October 2024
Health Science Interdisciplinary Center, Scuola Superiore Sant'Anna, Piazza Martiri della Libertà 33 (56127), Pisa, Italy.
Article Synopsis
- The study investigates the effects of short-term transcutaneous vagus nerve stimulation (tVNS) on heart function in patients with chronic heart failure (CHF) and low left ventricular ejection fraction (LVEF).
- 16 adults participated in the research, undergoing two trials of tVNS on different sides, with no significant changes in heart rate, blood pressure, or respiratory rate observed.
- The results showed that right-sided tVNS significantly improved cardio-vagal baroreflex gain, indicating potential benefits for CHF patients, while left-sided tVNS had no noticeable effect.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!